Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
19.59B
Market cap19.59B
Price-Earnings ratio
23.72
Price-Earnings ratio23.72
Dividend yield
1.05%
Dividend yield1.05%
Average volume
2.26M
Average volume2.26M
High today
$96.70
High today$96.70
Low today
$90.70
Low today$90.70
Open price
$95.31
Open price$95.31
Volume
2.03M
Volume2.03M
52 Week high
$108.29
52 Week high$108.29
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

With a market cap of 19.59B, Zimmer Biomet(ZBH) trades at $90.98. The stock has a price-to-earnings ratio of 23.72 and currently yields dividends of 1.05%.

On 2026-07-30, Zimmer Biomet(ZBH) stock traded between a low of $90.70 and a high of $96.70. Shares are currently priced at $90.98, which is +0.3% above the low and -5.9% below the high.

Zimmer Biomet(ZBH) shares are trading with a volume of 2.03M, against a daily average of 2.26M.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $108.29 at its peak.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $108.29 at its peak.

ZBH News

MarketWatch 2d
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Seeking Alpha 2d
Zimmer upgraded to Buy from Sell at UBS on growth and innovation

Zimmer Biomet (ZBH) traded higher on Tuesday after UBS analyst Patrick Wood assumed its coverage and upgraded the stock to Buy from Sell, citing the orthopedic...

Zimmer upgraded to Buy from Sell at UBS on growth and innovation
Simply Wall St 5d
Healthcare Dividend Stocks For Higher Rates With Zimmer Biomet STERIS And Quest

With the Federal Reserve sending mixed signals on future rate cuts and hikes, inflation estimates edging higher, and oil prices reacting to conflict in Iran, ma...

Healthcare Dividend Stocks For Higher Rates With Zimmer Biomet STERIS And Quest

Analyst ratings

72%

of 29 ratings
Buy
27.6%
Hold
72.4%
Sell
0%

More ZBH News

Simply Wall St 6d
How Zimmer Biomet’s New Asia Pacific President Shapes Its Robotics and Regional Strategy for ZBH Investors

Zimmer Biomet Holdings has appointed Chintan Desai as president of its Asia Pacific Region, effective 14 July 2026, succeeding Sang Yi after a transition period...

How Zimmer Biomet’s New Asia Pacific President Shapes Its Robotics and Regional Strategy for ZBH Investors
TipRanks 6d
Zimmer Biomet: Solid Orthopedics Franchise and Early-Stage Digital Investments Support Neutral Risk-Reward, Justifying Hold Rating

BTIG analyst Ryan Zimmerman has maintained their neutral stance on ZBH stock, giving a Hold rating on July 9. Claim 55% Off TipRanks Unlock powerful investing t...

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.